ロード中...
The influence of CYP 2C19*2 polymorphism on platelet function testing during single antiplatelet treatment with clopidogrel
BACKGROUND: Different platelet function tests can be used to evaluate the degree of achieved platelet inhibition in patients treated with clopidogrel. The presence of CYP 2C19*2 polymorphism can reduce the formation of the active metabolite of clopidogrel, resulting in less platelet inhibition. PATI...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3071307/ https://ncbi.nlm.nih.gov/pubmed/21426546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-9560-9-4 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|